Results 151 to 160 of about 48,361 (234)

Combined analysis of the MspI and XbaI polymorphisms in intron 22 of the factor VIII gene for detection of hemophilia A in a Korean population

, 2012
S.H. Park, Nack‐Gyun Chung, M. R. Lee, Seong‐Keun Yoo, Yoonhwa Choi   +4 more
openalex   +1 more source

Chimeric Antigen Receptor T‐Cell Therapy: More Than an Anti‐Cancer Drug

HLA, Volume 107, Issue 1, January 2026.
ABSTRACT Initially, chimeric antigen receptor (CAR) T‐cell therapy was developed to eliminate malignant B cells in haematological B‐cell malignancies by targeting CD19 and B‐cell maturation antigen. This approach achieved notable success, resulting in (malignant) B‐cell depletion and inducing clinical remission in cancer patients.
Hannah C. M. Schenk, Ilse Gille, Carolt Arana, Jordi Rovira, Eduard Palou, Fritz Diekmann, Dave L. Roelen, Mirjam H. M. Heemskerk, Sebastiaan Heidt   +8 more
wiley   +1 more source

Robot-assisted total hip arthroplasty following gene therapy for hemophilia a arthropathy: a case report. [PDF]

Arthroplasty
Wu C, Dai J, Chen Z, Shao Y, Wang X, He C.   +5 more
europepmc   +1 more source

Cardiovascular disease risk assessment in Japanese adults with hemophilia: Interim results of a multicenter study [PDF]

Yushi Chikasawa, Hisanori Kosuge, Azusa Nagao, Tomoko Yamaguchi, Masato Bingo, Mitsuhiro Ishikura, Tsukasa Osaki, Shun KANEKO, Ryui Miyashita, Akito Ichiki, Takashi Muramatsu, Mihoko Yotsumoto, Kagehiro Amano, Satoshi Hida, Takeshi Hagiwara, Kazuhiro Satomi, Ei Kinai   +16 more
openalex   +1 more source

A Case Report of Non‐Neutralizing Acquired Factor V Inhibitor Mimicking Deficiency: Diagnostic Challenges and Therapeutic Implications

Case Reports in Hematology, Volume 2026, Issue 1, 2026.
Acquired Factor V (FV) deficiency due to inhibitors is a rare coagulopathy that presents significant diagnostic and therapeutic challenges. We report the case of an 81‐year‐old male with persistent gross hematuria and severe coagulopathy, marked by prolonged prothrombin time (PT), activated partial thromboplastin time (aPTT), and critically low FV ...
Shreyas Kalantri, Pranali Pachika, Shiva Balasubramanian, Bayan Alquran, Morgan McCoy, Vivek Sharma, Andrew Song   +6 more
wiley   +1 more source

Splenic artery embolization for the treatment of spontaneous splenic rupture in hemophilia A: a case report. [PDF]

AME Case Rep
He X, Zhang J.
europepmc   +1 more source

The Use of Tranexamic Acid to Treat Melasma: A Systematic Review and Meta‐Analysis

Dermatologic Therapy, Volume 2026, Issue 1, 2026.
Introduction Tranexamic acid (TXA) is a synthetic derivative of the amino acid lysine that inhibits bleeding due to its effects on plasminogen conversion, approved by the FDA to treat menorrhagia and prevent bleeding in hemophilia patients undergoing dental extraction.
Nabila Scabine Pessotti, Vinicius Tassoni Civile, Talita Andrade Brandao, Felipe Ribeiro, Gisele Viana de Oliveira, Nathalia Sernizon Guimarães, Denise Steiner, Mahlatse Kgokolo   +7 more
wiley   +1 more source

Laparoscopic Cholecystectomy for Acute Cholecystitis in a Patient with Acquired Hemophilia A: A Case Report of Perioperative Hemostatic Management with Plasma Exchange. [PDF]

Surg Case Rep
Yasui K, Mashima H, Nishimori H, Yoshimoto M, Katsura Y, Taniguchi F, Sawada H, Ishida M, Sato D, Yoshida R, Choda Y, Yoshimitsu M, Nakano K, Shirakawa Y, Matsukawa H.   +14 more
europepmc   +1 more source

Transformative approaches in hemophilia management: from traditional therapies to prenatal stem cell treatment. [PDF]

Front Bioeng Biotechnol
Kao YT, Fan HC, Ro-Lin Chang G, Chen JK, Yen CC, Sufian M, Yang SH, Chen CM.   +7 more
europepmc   +1 more source

Postoperative bleeding complicated by hemophilia A following anal fistula surgery: A case report

Xue Chen, Rui Tian, Ze Chen, Longfang Quan, Shaosheng Bei   +4 more
openalex   +1 more source